{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:20:09Z","timestamp":1791724809589,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014108","name":"University of Texas Rio Grande Valley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.toxicon.2026.109092","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:08:00Z","timestamp":1775516880000},"page":"109092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Humanized synthetic nanobody library for antivenom development"],"prefix":"10.1016","volume":"277","author":[{"given":"Ying","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Coronado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casee","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2026.109092_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2026.109092_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012080","article-title":"Snakebite envenoming: a systematic review and meta-analysis of global morbidity and mortality","volume":"18","author":"Afroz","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.toxicon.2026.109092_bib3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41586-025-09661-0","article-title":"Nanobody-based recombinant antivenom for cobra, mamba and rinkhals bites","volume":"647","author":"Ahmadi","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2026.109092_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(94)90152-X","article-title":"On the interaction between single chain Fv antibodies and bacterial immunoglobulin-binding proteins","volume":"177","author":"Akerstr\u00f6m","year":"1994","journal-title":"J Immuno Methods"},{"key":"10.1016\/j.toxicon.2026.109092_bib5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1186\/s12951-024-02900-y","article-title":"Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years","volume":"22","author":"Alexander","year":"2024","journal-title":"Journal of Nanobiotechnoloy"},{"key":"10.1016\/j.toxicon.2026.109092_bib6","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3389\/fimmu.2017.01603","article-title":"Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics","volume":"8","author":"Bannas","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2026.109092_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/0471142735.im0217s103","article-title":"Single-domain antibodies and their utility","volume":"103","author":"Baral","year":"2013","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.toxicon.2026.109092_bib8","first-page":"E311","article-title":"Snakebite envenoming: a hidden health crisis","volume":"10","author":"Basnyat","year":"2022","journal-title":"The Lencet"},{"key":"10.1016\/j.toxicon.2026.109092_bib9","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1038\/s41467-024-48539-z","article-title":"In vivo neutralization of coral snake venoms with an oligoclonal nanobody mixture in a murine challenge model","volume":"15","author":"Benard-Valle","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2026.109092_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s42003-024-06019-6","article-title":"Tissue damaging toxins in snake venoms: mechanisms of action, pathophysiology and treatment strategies","volume":"7","author":"Bittenbinder","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.toxicon.2026.109092_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.prevetmed.2019.104729","article-title":"Snakebite in domestic animals: first global scoping review","volume":"170","author":"Bolon","year":"2019","journal-title":"Prev. Vet. Med."},{"key":"10.1016\/j.toxicon.2026.109092_bib12","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxicon.2026.109092_bib14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2020.05.006","article-title":"Causes and consequences of snake venom variation","volume":"41","author":"Casewell","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.toxicon.2026.109092_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.tree.2012.10.020","article-title":"Complex cocktails: the evolutionary novelty of venoms","volume":"28","author":"Casewell","year":"2013","journal-title":"Treads Ecol. Evol."},{"key":"10.1016\/j.toxicon.2026.109092_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/antib8010013","article-title":"Nanobody Engineering: toward next generation immunotherapies and diagnostics","volume":"8","author":"Chanier","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.toxicon.2026.109092_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coviro.2019.02.004","article-title":"VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design","volume":"34","author":"Chen","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.toxicon.2026.109092_bib17","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1038\/s41467-021-25777-z","article-title":"Cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies","volume":"12","author":"Chen","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2026.109092_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40409-017-0127-6","article-title":"Snakebite envenomation turns again into a neglected tropical disease","volume":"23","author":"Chippaux","year":"2017","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.toxicon.2026.109092_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/protein\/gzm037","article-title":"Repertoires of aggregation-resistant human antibody domains","volume":"20","author":"Christ","year":"2007","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.toxicon.2026.109092_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2025.2522838","article-title":"Discovery of broadly neutralizing VHHs against short-chain \u03b1-neurotoxins using a consensus toxin as an antigen","volume":"17","author":"Damsbo","year":"2025","journal-title":"mAbs"},{"key":"10.1016\/j.toxicon.2026.109092_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsb0996-803","article-title":"Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme","volume":"3","author":"Desmyter","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.toxicon.2026.109092_bib22","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1073\/pnas.1202866109","article-title":"General strategy for the generation of human antibody variable domains with increased aggregation resistance","volume":"109","author":"Dudgeon","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.toxicon.2026.109092_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0140-6736(17)31751-8","article-title":"Snake-bite envenoming: a priority neglected tropical disease","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2026.109092_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41587-024-02221-3","article-title":"Antivenom slithers back to life","volume":"42","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2026.109092_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-2836(02)01237-8","article-title":"Biophysical properties of human antibody variable domains","volume":"325","author":"Ewert","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxicon.2026.109092_bib26","article-title":"From Liama to Nanobody: a streamlined workflow for the generation of functionalized VHHs","volume":"14","author":"Eyssen","year":"2024","journal-title":"Bio-protocol"},{"key":"10.1016\/j.toxicon.2026.109092_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2024.100865","article-title":"Nanobodies: from high-throughput identification to therapeutic development","volume":"23","author":"Fridy","year":"2024","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.toxicon.2026.109092_bib28","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1016\/j.cell.2025.03.050","article-title":"Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodies","volume":"188","author":"Glanville","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.toxicon.2026.109092_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1399438","article-title":"Prospects for the computational humanization of antibodies and nanobodies","volume":"15","author":"Gordon","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2026.109092_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/187152811797200669","article-title":"Antivenoms for snakebite envenomings. Inflamm","volume":"10","author":"Guti\u00e9rrez","year":"2011","journal-title":"Allergy Drug Targets"},{"key":"10.1016\/j.toxicon.2026.109092_bib31","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1038\/s41467-023-43510-w","article-title":"Repurposed drugs and their combinations prevent morbidity-inducing dermonecrosis caused by diverse cytotoxic snake venoms","volume":"14","author":"Hall","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2026.109092_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2026.109092_bib33","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server: a leap forward in integrative modelling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nature Prot"},{"key":"10.1016\/j.toxicon.2026.109092_bib34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1586\/erm.10.62","article-title":"Nanobodies(R): proficient tools in diagnostics","volume":"10","author":"Huang","year":"2010","journal-title":"Expert Rev. Mol. Diagn"},{"key":"10.1016\/j.toxicon.2026.109092_bib35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41594-020-0469-6","article-title":"Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2","volume":"27","author":"Huo","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.toxicon.2026.109092_bib36","first-page":"18","article-title":"Toxin transcripts in Crotalus atrox venom and in silico structures of toxins","volume":"10","author":"Jia","year":"2020","journal-title":"J. Venom Res."},{"key":"10.1016\/j.toxicon.2026.109092_bib37","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.3390\/ijms24065994","article-title":"NANOBODIES\u00ae: a review of diagnostic and therapeutic applications","volume":"24","author":"Jin","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.toxicon.2026.109092_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The therapeutic potential of nanobodies","volume":"34","author":"Jov\u010devska","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.toxicon.2026.109092_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050218","article-title":"The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths","volume":"5","author":"Kasturiratne","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.toxicon.2026.109092_bib40","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1126\/scitranslmed.adk1867","article-title":"Synthetic development of a broadly neutralizing antibody against snake venom long-chain \u03b1-neurotoxins","volume":"16","author":"Khalek","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.toxicon.2026.109092_bib41","article-title":"A single-domain antibody library based on a stability-engineered human VH3 scaffold","volume":"14","author":"Lee","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2026.109092_bib42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxicon.2013.09.010","article-title":"Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms","volume":"76","author":"Le\u00f3n","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2026.109092_bib44","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1038\/s41467-023-41631-w","article-title":"Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumors","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2026.109092_bib43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12951-022-01417-6","article-title":"Highly potent multivalent VHH antibodies against Chikungunya isolated from an alpaca na\u00efve phage display library","volume":"20","author":"Li","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.toxicon.2026.109092_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(18)31224-8","article-title":"Vulnerability to snakebite envenoming: a global mapping of hotspots","volume":"392","author":"Longbottom","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2026.109092_bib46","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1016\/S2214-109X(21)00549-0","article-title":"Assessment of the effect of snakebite on health and socioeconomic factors using a one Health perspective in the Terai region of Nepal: a cross-sectional study","volume":"10","author":"Martins","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.toxicon.2026.109092_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41594-018-0028-6","article-title":"Yeast surface display platform for rapid discovery of conformationally selective nanobodies","volume":"25","author":"McMahon","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.toxicon.2026.109092_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.16228","article-title":"NaLi-H1: a universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies","volume":"5","author":"Moutel","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.toxicon.2026.109092_bib49","doi-asserted-by":"crossref","first-page":"P907","DOI":"10.1016\/S0140-6736(23)01698-7","article-title":"Strengthening global snakebite data for WHO's goal for 2030","volume":"403","author":"Munshi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2026.109092_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/antib11010010","article-title":"Construction of a humanized artificial VHH library reproducing structural features of camelid VHHs for therapeutics","volume":"11","author":"Murakami","year":"2022","journal-title":"Antibodies"},{"key":"10.1016\/j.toxicon.2026.109092_bib51","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.toxicon.2026.109092_bib52","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1111\/febs.15515","article-title":"A guide to: generation and design of nanobodies","volume":"288","author":"Muyldermans","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.toxicon.2026.109092_bib53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s42256-023-00778-3","article-title":"Assessing antibody and nanobody nativeness for hit selection and humanization with AbNatiV","volume":"6","author":"Ramon","year":"2024","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.toxicon.2026.109092_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116726","article-title":"Preclinical development of humanized monoclonal antibodies against CD169 as a broad antiviral therapeutic strategy","volume":"175","author":"Resa-Infante","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.toxicon.2026.109092_bib55","article-title":"Construction of a nanobodies phage display library from an Escherichia coli immunized dromedary. Iran","volume":"18","author":"Salhi","year":"2020","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.toxicon.2026.109092_bib56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.str.2021.11.006","article-title":"Llamanade: an open-source computational pipeline for robust nanobody humanization","volume":"30","author":"Sang","year":"2022","journal-title":"Structure"},{"key":"10.1016\/j.toxicon.2026.109092_bib57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxicon.2026.109092_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/protein\/gzaa028","article-title":"Structure- and sequence-based design of synthetic single-domain antibody libraries","volume":"33","author":"Sevy","year":"2020","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.toxicon.2026.109092_bib59","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/pmic.200401273","article-title":"Design, construction, and characterization of a large synthetic human antibody phage display library","volume":"5","author":"Silacci","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.toxicon.2026.109092_bib60","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12951-025-03243-y","article-title":"A bivalent spike-targeting nanobody with anti-sarbecovirus activity","volume":"23","author":"Swart","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.toxicon.2026.109092_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109092_bib62","first-page":"283","article-title":"The process using a synthetic library that generates multiple diverse human single domain antibodies","volume":"7","author":"Tornetta","year":"2024","journal-title":"Antib. Ther."},{"key":"10.1016\/j.toxicon.2026.109092_bib64","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1074\/jbc.M806889200","article-title":"General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold","volume":"284","author":"Vincke","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2026.109092_bib63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41586-024-08393-x","article-title":"De novo designed proteins neutralize lethal snake venom toxins","volume":"639","author":"V\u00e1zquez-Torres","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2026.109092_bib65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/toxins11040193","article-title":"Long-term effects of snake envenoming","volume":"11","author":"Waiddyanatha","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2026.109092_bib66","article-title":"Research progress and applications of multivalent, multispecific and modified nanobodies for disease treatment","volume":"18","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2026.109092_bib67","series-title":"Snakebite Envenoming","year":"2023"},{"key":"10.1016\/j.toxicon.2026.109092_bib69","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41586-021-03676-z","article-title":"Nanobodies from camelid mice and Llamas neutralize SARS-CoV-2 variants","volume":"595","author":"Xu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2026.109092_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","article-title":"Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities","volume":"13","author":"Xu","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.toxicon.2026.109092_bib70","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fonc.2020.01182","article-title":"Nanobodies: next generation of cancer diagnostics and therapeutics","volume":"23","author":"Yang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.toxicon.2026.109092_bib71","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34317","article-title":"Synthetic single domain antibodies for the conformational trapping of membrane proteins","volume":"7","author":"Zimmermann","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.toxicon.2026.109092_bib72","article-title":"Engineered multivalent nanobodies potently and broadly neutralize SARS-CoV-2 variants","volume":"4","author":"Zupancic","year":"2021","journal-title":"Adv. Ther."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010126001108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010126001108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:17:00Z","timestamp":1776413820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010126001108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":72,"alternative-id":["S0041010126001108"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2026.109092","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humanized synthetic nanobody library for antivenom development","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2026.109092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109092"}}